Ebola Vaccine Trial in DR Congo Begins

The Democratic Republic of the Congo is initiating a trial of the Ervebo Ebola vaccine to assess its effectiveness against the current outbreak caused by the rarer Bundibugyo species. The outbreak has resulted in nearly 2,500 deaths, making it the deadliest in the country's history. The World Health Organization warns that Ebola is spreading rapidly and expanding over a large area, with efforts hampered by ongoing conflict and healthcare challenges.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل